Today, the annual general meeting of 2023 was held in
Modus Therapeutics’ Annual General Meeting on
- That no dividend would be paid.
- To discharge the board members and the managing director from liability with respect to their management of the company for the financial year 2022.
- That the board of directors shall comprise three board members without any deputies.
- To re-elect the board members
Viktor Drvota ,Ellen Donnelly andTorsten Goesch and to re-elect Viktor Drovta as the chairman of the board. - To re-elect Ernst & Young Aktiebolag as auditor.
- To adopt principles for the Nomination Committee, in accordance with the Nomination Committee’s proposal.
- To authorize the board, for a period that does not extend past the date of the next annual general meeting, on one or several occasions, with or without pre-emptive rights for the shareholders, to resolve on the issue of new shares, convertibles and/or warrants.
- To approve a bridge financing facility of up to
SEK 7 million fromKarolinska Development .
© Modular Finance, source